Cervical cone biopsy for persistent HPV or abnormal cell results
Part of Cancer, Infections, Women’s health & pregnancy clinical trials.
This study tests whether removing a small piece of the cervix (cone biopsy) can help diagnose hidden precancer when regular tests are unclear. It may help you get a clearer diagnosis if you have ongoing HPV or abnormal cell changes.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You had abnormal cervical screening results, but your biopsy did not show precancerous changes.
- You have at least one of these risk factors: HPV type 16 or 18 for more than 2 years, high HPV integration levels, colposcopy suggesting precancer, or a Pap test showing certain abnormal cell types.
- You are not pregnant.
- You do not have signs of vaginal precancer (VaIN).
- You do not have an active cancer elsewhere that is not cured.
- You do not have severe acute infections or major health problems that would make the procedure risky.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at better ways to manage early precancerous changes in the cervix (called high-grade lesions) without surgery. It aims to find which approaches work best for women who have not been vaccinated against HPV.
This trial tests whether giving an HPV vaccine after a cone biopsy (a surgery to remove abnormal cells from the cervix) helps prevent the HPV-related disease from coming back. It may be an option for patients who have had treatment for cervical dysplasia and have not been vaccinated against HPV before.
This trial studies a “conservative” (less immediate) approach to a specific abnormal cervix finding to see if it can be managed safely for people who want future pregnancies. It uses close follow-up visits instead of immediate procedures for certain results.
This trial checks whether “therapy abstention” (not treating right away) and close monitoring is safe for certain high-grade cervical cell changes. It may help some people avoid immediate procedures while still catching any progression early.
This study looks at a simple DNA test on your cervical cells to predict whether your condition (HSIL with positive margins) might come back after conization. This could help doctors decide if you need more treatment or just careful monitoring.
This study compares different ways to screen for cervical cancer in women living with HIV. It aims to find the most effective and practical screening approach for this group.
Hear when a new Cervical Intraepithelial Neoplasia trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.